Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid

被引:18
作者
Chengalvala, MV [1 ]
Bhat, RA [1 ]
Bhat, BM [1 ]
Vernon, SK [1 ]
Lubeck, MD [1 ]
机构
[1] Wyeth Ayerst Res, Discovery Res, Philadelphia, PA 19101 USA
关键词
T cell-B cell collaboration; hepatitis B; epitopic suppression; vaccination;
D O I
10.1016/S0264-410X(98)00318-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The currently marketed hepatitis B Vaccines in the U.S. are based on the recombinant major hepatitis B surface antigen (HBsAg) of hepatitis B virus. Although a large majority of individuals develop protective immunity to HBV-induced disease after three immunizations, routinely a small but a significant percentage of the human population does not respond well to these vaccines. In this report, we describe the generation of a novel HBsAg molecule containing a T-h epitope derived from tetanus toroid (TT). Using recombinant DNA technology, the TT T-h epitope (TTe) was inserted into the HBsAg coding sequence. Using a recombinant adenovirus expression system, HBsAg-TTe chimeric protein was produced in A549 cells and found to be secreted into culture medium as 22 nm particles. The chimeric HBsAg particles were readily purified by immunoaffinity chromatography and their immunogenicity was evaluated relative to native HBsAg produced in an adenovirus expression system. When evaluated in inbred and outbred strains of mice, HBsAg-TTe was shown to enhance several-fold the anti-HBs response relative to native HBsAg. Further enhanced responses were observed in mice primed with TT. This highly immunogenic form of HBsAg has promise as an improved HBsAg subunit vaccine. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1035 / 1041
页数:7
相关论文
共 33 条
[1]   FINE SPECIFICITY OF REGULATORY T-CELLS .2. SUPPRESSOR AND HELPER T-CELLS ARE INDUCED BY DIFFERENT REGIONS OF HEN EGG-WHITE LYSOZYME IN A GENETICALLY NONRESPONDER MOUSE STRAIN [J].
ADORINI, L ;
HARVEY, MA ;
MILLER, A ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (02) :293-306
[2]  
BERZOFSKY JA, 1987, ANTIGENS, V7, P1
[3]   ANTIBODY-RESPONSES TO RECOMBINANT AND PLASMA DERIVED HEPATITIS-B VACCINES [J].
BROWN, SE ;
STANLEY, C ;
HOWARD, CR ;
ZUCKERMAN, AJ ;
STEWARD, MW .
BRITISH MEDICAL JOURNAL, 1986, 292 (6514) :159-161
[4]   HELPER INTERLEUKINS ARE PRODUCED BY BOTH CD4 AND CD8 SPLENIC T-CELLS AFTER MITOGEN STIMULATION [J].
CARDELL, S ;
SANDER, B ;
MOLLER, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (10) :2495-2500
[5]   IMMUNOGENICITY OF HIGH EXPRESSION ADENOVIRUS HEPATITIS-B VIRUS RECOMBINANT VACCINES IN DOGS [J].
CHENGALVALA, MV ;
BHAT, BM ;
BHAT, R ;
LUBECK, MD ;
MIZUTANI, S ;
DAVIS, AR ;
HUNG, PP .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :125-131
[6]   Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees [J].
Chengalvala, MV ;
Bhat, BM ;
Bhat, RA ;
Dheer, SK ;
Lubeck, MD ;
Purcell, RH ;
Murthy, KK .
VACCINE, 1997, 15 (03) :335-339
[7]  
CROSNIER J, 1981, LANCET, V1, P797
[8]   HEPATITIS-B VACCINATION IN CHRONIC-ALCOHOLICS [J].
DEGOS, F ;
DUHAMEL, G ;
BRECHOT, C ;
NALPAS, B ;
COUROUCE, AM ;
TRON, F ;
BERTHELOT, P .
JOURNAL OF HEPATOLOGY, 1986, 2 (03) :402-409
[9]   STRUCTURAL FACTORS MODULATE THE ACTIVITY OF ANTIGENIC POLIOVIRUS SEQUENCES EXPRESSED ON HYBRID HEPATITIS-B SURFACE-ANTIGEN PARTICLES [J].
DELPEYROUX, F ;
VANWEZEL, E ;
BLONDEL, B ;
CRAINIC, R .
JOURNAL OF VIROLOGY, 1990, 64 (12) :6090-6100
[10]  
ELLIS RW, 1990, NEW GENERATION VACCI, P439